{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:38:54Z","timestamp":1790113134073,"version":"4.0.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10133-4","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:04:49Z","timestamp":1766232289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumor-mediated remote regulation of peripheral blood platelets"],"prefix":"10.1007","volume":"42","author":[{"given":"Ruohao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"10133_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100380","author":"NB Abdol Razak","year":"2018","unstructured":"Abdol Razak NB, et al. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018. https:\/\/doi.org\/10.3390\/cancers10100380.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10133_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.beha.2008.11.002","volume":"22","author":"A Aharon","year":"2009","unstructured":"Aharon A, Brenner B. Microparticles, thrombosis and cancer. Best Pract Res Clin Haematol. 2009;22(1):61\u20139.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6774","key":"10133_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/35004599","volume":"404","author":"K Akashi","year":"2000","unstructured":"Akashi K, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193\u20137.","journal-title":"Nature"},{"issue":"6","key":"10133_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","volume":"7","author":"RH Aster","year":"2009","unstructured":"Aster RH, et al. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7(6):911\u20138.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10133_CR5","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3324\/haematol.2017.185165","volume":"103","author":"CCFM Baaten","year":"2018","unstructured":"Baaten CCFM, et al. Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy. Haematologica. 2018;103(9):1557\u201367.","journal-title":"Haematologica"},{"issue":"659","key":"10133_CR6","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.3399\/bjgp17X691109","volume":"67","author":"SE Bailey","year":"2017","unstructured":"Bailey SE, et al. Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data. Br J Gen Pract. 2017a;67(659):e405\u201313.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10133_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/fampra\/cmw100","volume":"34","author":"SER Bailey","year":"2017","unstructured":"Bailey SER, et al. How useful is thrombocytosis in predicting an underlying cancer in primary care? A systematic review. Fam Pract. 2017;34(1):4\u201310.","journal-title":"Fam Pract"},{"issue":"2","key":"10133_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"NM Bambace","year":"2011","unstructured":"Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011;9(2):237\u201349.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10133_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1055\/s-0037-1615913","volume":"82","author":"OP Barry","year":"1999","unstructured":"Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost. 1999;82(2):794\u2013800.","journal-title":"Thromb Haemost"},{"issue":"9","key":"10133_CR10","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1172\/JCI119385","volume":"99","author":"OP Barry","year":"1997","unstructured":"Barry OP, et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997;99(9):2118\u201327.","journal-title":"J Clin Invest"},{"issue":"1","key":"10133_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1172\/JCI2592","volume":"102","author":"OP Barry","year":"1998","unstructured":"Barry OP, et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest. 1998;102(1):136\u201344.","journal-title":"J Clin Invest"},{"issue":"5","key":"10133_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","volume":"28","author":"MG Best","year":"2015","unstructured":"Best MG, et al. RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell. 2015;28(5):666\u201376.","journal-title":"Cancer Cell"},{"issue":"22","key":"10133_CR13","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1182\/blood-2009-08-238311","volume":"116","author":"E Bianchi","year":"2010","unstructured":"Bianchi E, et al. c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. Blood. 2010;116(22):e99-110.","journal-title":"Blood"},{"key":"10133_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665534","volume":"11","author":"A Braun","year":"2021","unstructured":"Braun A, et al. Platelet-cancer interplay: molecular mechanisms and new therapeutic avenues. Front Oncol. 2021;11:665534.","journal-title":"Front Oncol"},{"key":"10133_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217044","volume":"607","author":"S Bravaccini","year":"2024","unstructured":"Bravaccini S, et al. The use of platelets as a clinical tool in oncology: opportunities and challenges. Cancer Lett. 2024;607:217044.","journal-title":"Cancer Lett"},{"issue":"1","key":"10133_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-025-00676-x","volume":"14","author":"C Cai","year":"2025","unstructured":"Cai C, et al. Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities. Exp Hematol Oncol. 2025;14(1):83.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"10133_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1752-8062.2010.00226.x","volume":"3","author":"DC Calverley","year":"2010","unstructured":"Calverley DC, et al. Significant downregulation of platelet gene expression in metastatic lung cancer. Clin Transl Sci. 2010;3(5):227\u201332.","journal-title":"Clin Transl Sci"},{"key":"10133_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030788","author":"MV Catani","year":"2020","unstructured":"Catani MV, et al. The \u201cJanus face\u201d of platelets in cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030788.","journal-title":"Int J Mol Sci"},{"key":"10133_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116022","author":"PK Chaudhary","year":"2022","unstructured":"Chaudhary PK, Kim S, Kim S. An insight into recent advances on platelet function in health and disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116022.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10133_CR20","first-page":"1574","volume":"54","author":"YQ Chen","year":"1994","unstructured":"Chen YQ, et al. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. 1994;54(6):1574\u20139.","journal-title":"Cancer Res"},{"key":"10133_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-015-0418-x","volume":"14","author":"N Chen","year":"2015","unstructured":"Chen N, et al. Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma. Mol Cancer. 2015;14:140.","journal-title":"Mol Cancer"},{"issue":"3","key":"10133_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/bmm-2020-0203","volume":"15","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Economical and easily detectable markers of digestive tumors: platelet parameters. Biomark Med. 2021;15(3):157\u201366.","journal-title":"Biomark Med"},{"issue":"13","key":"10133_CR23","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/NEJMra010501","volume":"346","author":"DB Cines","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346(13):995\u20131008.","journal-title":"N Engl J Med"},{"issue":"18","key":"10133_CR24","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","volume":"17","author":"J Coward","year":"2011","unstructured":"Coward J, et al. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res. 2011;17(18):6083\u201396.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10133_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.21307\/immunohematology-2019-099","volume":"30","author":"BR Curtis","year":"2014","unstructured":"Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology. 2014;30(2):55\u201365.","journal-title":"Immunohematology"},{"issue":"3","key":"10133_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","volume":"122","author":"MM Denis","year":"2005","unstructured":"Denis MM, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005;122(3):379\u201391.","journal-title":"Cell"},{"issue":"3","key":"10133_CR27","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3390\/curroncol30030258","volume":"30","author":"P Detopoulou","year":"2023","unstructured":"Detopoulou P, et al. Relation of mean platelet volume (MPV) with cancer: a systematic review with a focus on disease outcome on twelve types of cancer. Curr Oncol. 2023;30(3):3391\u2013420.","journal-title":"Curr Oncol"},{"issue":"11","key":"10133_CR28","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.122.321861","volume":"132","author":"T Dudiki","year":"2023","unstructured":"Dudiki T, et al. Mechanism of tumor-platelet communications in cancer. Circ Res. 2023;132(11):1447\u201361.","journal-title":"Circ Res"},{"issue":"10","key":"10133_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026125","volume":"6","author":"K Egan","year":"2011","unstructured":"Egan K, et al. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One. 2011;6(10):e26125.","journal-title":"PLoS One"},{"issue":"3","key":"10133_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/09537104.2015.1083543","volume":"27","author":"JD Eicher","year":"2016","unstructured":"Eicher JD, et al. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction. Platelets. 2016;27(3):230\u20139.","journal-title":"Platelets"},{"key":"10133_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9100142","author":"O Elaskalani","year":"2017","unstructured":"Elaskalani O, et al. The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance. Cancers (Basel). 2017. https:\/\/doi.org\/10.3390\/cancers9100142.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10133_CR32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1160\/TH10-11-0757","volume":"105","author":"P Ferroni","year":"2011","unstructured":"Ferroni P, et al. An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients. Thromb Haemost. 2011;105(5):931\u20132.","journal-title":"Thromb Haemost"},{"issue":"1","key":"10133_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00616-3","volume":"14","author":"A Gao","year":"2023","unstructured":"Gao A, Zhang L, Zhong D. Chemotherapy-induced thrombocytopenia: literature review. Discover Oncol. 2023a;14(1):10.","journal-title":"Discover Oncol"},{"issue":"6","key":"10133_CR34","first-page":"579","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao Y, et al. Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study. Protein Cell. 2023b;14(6):579\u201390.","journal-title":"Protein Cell"},{"issue":"1","key":"10133_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138161211795049804","volume":"17","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm des. 2011;17(1):47\u201358.","journal-title":"Curr Pharm des"},{"issue":"11","key":"10133_CR36","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","volume":"122","author":"JE Geddings","year":"2013","unstructured":"Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 2013;122(11):1873\u201380.","journal-title":"Blood"},{"issue":"5","key":"10133_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.stem.2019.03.002","volume":"24","author":"T Graf","year":"2019","unstructured":"Graf T. Transcription factor stoichiometry drives cell fate: single-cell proteomics to the rescue. Cell Stem Cell. 2019;24(5):673\u20134.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10133_CR38","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1039\/C5TB02521D","volume":"4","author":"S Guan","year":"2016","unstructured":"Guan S, et al. A layered drug nanovehicle toward targeted cancer imaging and therapy. J Mater Chem B. 2016;4(7):1331\u20136.","journal-title":"J Mater Chem B"},{"issue":"6","key":"10133_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle M, et al. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33(6):965\u201383.","journal-title":"Cancer Cell"},{"issue":"1","key":"10133_CR40","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1038\/s41467-021-27303-7","volume":"12","author":"C Hinterleitner","year":"2021","unstructured":"Hinterleitner C, et al. Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer. Nat Commun. 2021;12(1):7005.","journal-title":"Nat Commun"},{"issue":"4","key":"10133_CR41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/1078155210380293","volume":"17","author":"A Hitron","year":"2011","unstructured":"Hitron A, et al. Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors. J Oncol Pharm Pract. 2011;17(4):312\u20139.","journal-title":"J Oncol Pharm Pract"},{"key":"10133_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218169","author":"DH Hufnagel","year":"2020","unstructured":"Hufnagel DH, et al. Platelets, thrombocytosis, and ovarian cancer prognosis: surveying the landscape of the literature. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218169.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10133_CR43","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.immuni.2007.06.004","volume":"26","author":"H Iwasaki","year":"2007","unstructured":"Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity. 2007;26(6):726\u201340.","journal-title":"Immunity"},{"issue":"7","key":"10133_CR44","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","volume":"143","author":"P Jurasz","year":"2004","unstructured":"Jurasz P, Alonso-Escolano D, Radomski MW. Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol. 2004;143(7):819\u201326.","journal-title":"Br J Pharmacol"},{"key":"10133_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ebiom.2018.11.004","volume":"38","author":"P Kanlikilicer","year":"2018","unstructured":"Kanlikilicer P, et al. Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018;38:100\u201312.","journal-title":"EBioMedicine"},{"issue":"1","key":"10133_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1182\/bloodadvances.2016000067","volume":"1","author":"R Kapur","year":"2016","unstructured":"Kapur R, Semple JW. Platelets as immune-sensing cells. Blood Adv. 2016;1(1):10\u20134.","journal-title":"Blood Adv"},{"issue":"9","key":"10133_CR47","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","volume":"98","author":"A Kaser","year":"2001","unstructured":"Kaser A, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98(9):2720\u20135.","journal-title":"Blood"},{"issue":"36","key":"10133_CR48","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/onc.2012.447","volume":"32","author":"BA Kerr","year":"2013","unstructured":"Kerr BA, et al. Platelets govern pre-metastatic tumor communication to bone. Oncogene. 2013;32(36):4319\u201324.","journal-title":"Oncogene"},{"issue":"19","key":"10133_CR49","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"H Kopp","year":"2009","unstructured":"Kopp H, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 2009;69(19):7775\u201383.","journal-title":"Cancer Res"},{"issue":"3","key":"10133_CR50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41416-021-01627-z","volume":"126","author":"A Krishnan","year":"2022","unstructured":"Krishnan A, Thomas S. Toward platelet transcriptomics in cancer diagnosis, prognosis and therapy. Br J Cancer. 2022;126(3):316\u201322.","journal-title":"Br J Cancer"},{"issue":"3","key":"10133_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5578\/tt.202403838","volume":"72","author":"HG Kurt","year":"2024","unstructured":"Kurt HG, et al. Association of mean platelet volume (MPV), MPV\/PLATELET (PLT) ratio, and lymphocyte\/monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor. Tuberk Toraks. 2024;72(3):197\u2013207.","journal-title":"Tuberk Toraks"},{"issue":"12","key":"10133_CR52","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","volume":"2","author":"HS Kuznetsov","year":"2012","unstructured":"Kuznetsov HS, et al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov. 2012;2(12):1150\u201365.","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"10133_CR53","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.thromres.2018.01.016","volume":"164","author":"M Levi","year":"2018","unstructured":"Levi M. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers. Thromb Res. 2018;164(Suppl 1):S77\u201381.","journal-title":"Thromb Res"},{"issue":"4","key":"10133_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1055\/s-0039-1687890","volume":"45","author":"M Levi","year":"2019","unstructured":"Levi M. Disseminated intravascular coagulation in cancer: an update. Semin Thromb Hemost. 2019;45(4):342\u20137.","journal-title":"Semin Thromb Hemost"},{"issue":"23","key":"10133_CR55","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.7314\/APJCP.2014.15.23.10501","volume":"15","author":"J Li","year":"2014","unstructured":"Li J, et al. Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prev. 2014;15(23):10501\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"10133_CR56","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.2147\/CMAR.S221976","volume":"11","author":"M Li","year":"2019","unstructured":"Li M, et al. Platelet volume is reduced in metastasing breast cancer: blood profiles reveal significant shifts. Cancer Manag Res. 2019;11:9067\u201372.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10133_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","volume":"21","author":"W Li","year":"2022","unstructured":"Li W, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Mol Cancer. 2022;21(1):25.","journal-title":"Mol Cancer"},{"issue":"1","key":"10133_CR58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, et al. The dynamic role of platelets in cancer progression and their therapeutic implications. Nat Rev Cancer. 2024;24(1):72\u201387.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10133_CR59","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7150\/ijms.85704","volume":"21","author":"S Liang","year":"2024","unstructured":"Liang S, et al. Metabolomics analysis and diagnosis of lung cancer: insights from diverse sample types. Int J Med Sci. 2024;21(2):234\u201352.","journal-title":"Int J Med Sci"},{"issue":"2","key":"10133_CR60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1182\/blood-2014-03-562538","volume":"124","author":"RJ Lin","year":"2014","unstructured":"Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood. 2014;124(2):184\u20137.","journal-title":"Blood"},{"issue":"7","key":"10133_CR61","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1021\/acs.nanolett.9b01785","volume":"19","author":"S Liu","year":"2019","unstructured":"Liu S, et al. Tumor-specific silencing of tissue factor suppresses metastasis and prevents cancer-associated hypercoagulability. Nano Lett. 2019;19(7):4721\u201330.","journal-title":"Nano Lett"},{"key":"10133_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.857865","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Tumor-educated platelets facilitate thrombus formation through migration. Front Oncol. 2022;12:857865.","journal-title":"Front Oncol"},{"key":"10133_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzaf031","author":"H Luo","year":"2025","unstructured":"Luo H, et al. PlateletBase: a comprehensive knowledgebase for platelet research and disease insights. Genomics Proteomics Bioinform. 2025. https:\/\/doi.org\/10.1093\/gpbjnl\/qzaf031.","journal-title":"Genomics Proteomics Bioinform"},{"issue":"5","key":"10133_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0049-3848(83)90255-4","volume":"32","author":"JF Martin","year":"1983","unstructured":"Martin JF, et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32(5):443\u201360.","journal-title":"Thromb Res"},{"key":"10133_CR65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2016.01.006","volume":"139","author":"S Mezouar","year":"2016","unstructured":"Mezouar S, et al. Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences. Thromb Res. 2016;139:65\u201376.","journal-title":"Thromb Res"},{"issue":"2","key":"10133_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-019-1367-x","volume":"10","author":"S Miao","year":"2019","unstructured":"Miao S, et al. Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcgammaRIIa. Cell Death Dis. 2019;10(2):87.","journal-title":"Cell Death Dis"},{"issue":"5","key":"10133_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/RLU.0000000000004130","volume":"47","author":"JA Naveed Ahmad","year":"2022","unstructured":"Naveed Ahmad JA, et al. Severe thrombocytopenia in patients with advanced neuroendocrine tumor treated with peptide receptor radioligand therapy. Clin Nucl Med. 2022;47(5):409\u201313.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10133_CR68","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09537104.2018.1453059","volume":"29","author":"AK Olsson","year":"2018","unstructured":"Olsson AK, Cedervall J. The pro-inflammatory role of platelets in cancer. Platelets. 2018;29(6):569\u201373.","journal-title":"Platelets"},{"issue":"26","key":"10133_CR69","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1200\/JCO.22.02555","volume":"41","author":"N Oosterom","year":"2023","unstructured":"Oosterom N, et al. Severe hepatopathy in National Wilms Tumor Studies 3\u20135: prevalence, clinical features, and outcomes after reintroduction of chemotherapy. J Clin Oncol. 2023;41(26):4247\u201356.","journal-title":"J Clin Oncol"},{"issue":"12","key":"10133_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100824","volume":"3","author":"E Otles","year":"2022","unstructured":"Otles E, et al. Teaching artificial intelligence as a fundamental toolset of medicine. Cell Rep Med. 2022;3(12):100824.","journal-title":"Cell Rep Med"},{"issue":"3","key":"10133_CR71","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/clinchem\/hvaa249","volume":"67","author":"C Oudejans","year":"2021","unstructured":"Oudejans C, et al. Circular RNA sequencing of maternal platelets: a novel tool for the identification of pregnancy-specific biomarkers. Clin Chem. 2021;67(3):508\u201317.","journal-title":"Clin Chem"},{"key":"10133_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030730","author":"A Palacios-Acedo","year":"2022","unstructured":"Palacios-Acedo A, et al. Platelet and cancer-cell interactions modulate cancer-associated thrombosis risk in different cancer types. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14030730.","journal-title":"Cancers (Basel)"},{"issue":"44","key":"10133_CR73","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/25\/44\/445101","volume":"25","author":"A Pandey","year":"2014","unstructured":"Pandey A, et al. Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery. Nanotechnology. 2014;25(44):445101.","journal-title":"Nanotechnology"},{"issue":"1","key":"10133_CR74","first-page":"213","volume":"10","author":"LM Pedersen","year":"2003","unstructured":"Pedersen LM, Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep. 2003;10(1):213\u20136.","journal-title":"Oncol Rep"},{"issue":"6","key":"10133_CR75","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/1097-0142(19890915)64:6<1366::AID-CNCR2820640632>3.0.CO;2-A","volume":"64","author":"L Penchansky","year":"1989","unstructured":"Penchansky L, Taylor SR, Krause JR. Three infants with acute megakaryoblastic leukemia simulating metastatic tumor. Cancer. 1989;64(6):1366\u201371.","journal-title":"Cancer"},{"issue":"2","key":"10133_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10456-012-9259-z","volume":"15","author":"JE Peterson","year":"2012","unstructured":"Peterson JE, et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis. 2012;15(2):265\u201373.","journal-title":"Angiogenesis"},{"key":"10133_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2025.109320","volume":"250","author":"AE Pijning","year":"2025","unstructured":"Pijning AE, Hogg PJ. Disulfide bond control of platelet alphaIIbbeta3 integrin. Thromb Res. 2025;250:109320.","journal-title":"Thromb Res"},{"issue":"12","key":"10133_CR78","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1101\/gr.164178.113","volume":"24","author":"M Pimkin","year":"2014","unstructured":"Pimkin M, et al. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis. Genome Res. 2014;24(12):1932\u201344.","journal-title":"Genome Res"},{"issue":"12","key":"10133_CR79","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.106.658641","volume":"115","author":"N Raghavachari","year":"2007","unstructured":"Raghavachari N, et al. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation. 2007;115(12):1551\u201362.","journal-title":"Circulation"},{"issue":"4","key":"10133_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.thromres.2010.10.012","volume":"127","author":"MA Refaai","year":"2011","unstructured":"Refaai MA, et al. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res. 2011;127(4):287\u201391.","journal-title":"Thromb Res"},{"key":"10133_CR81","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejca.2017.04.010","volume":"80","author":"S Sabrkhany","year":"2017","unstructured":"Sabrkhany S, et al. A combination of platelet features allows detection of early-stage cancer. Eur J Cancer. 2017;80:5\u201313.","journal-title":"Eur J Cancer"},{"key":"10133_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jprot.2018.02.011","volume":"177","author":"S Sabrkhany","year":"2018","unstructured":"Sabrkhany S, et al. Exploration of the platelet proteome in patients with early-stage cancer. J Proteomics. 2018;177:65\u201374.","journal-title":"J Proteomics"},{"key":"10133_CR83","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2024.07.013","volume":"373","author":"A Safdar","year":"2024","unstructured":"Safdar A, et al. From bench to bedside: platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery. J Control Release. 2024;373:128\u201344.","journal-title":"J Control Release"},{"issue":"2","key":"10133_CR84","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cllc.2022.12.012","volume":"24","author":"B Sandfeld-Paulsen","year":"2023","unstructured":"Sandfeld-Paulsen B, Aggerholm-Pedersen N, Winther-Larsen A. Pretreatment platelet count is a prognostic marker in lung cancer: a Danish registry-based cohort study. Clin Lung Cancer. 2023;24(2):175\u201383.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10133_CR85","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5152\/tjg.2025.24540","volume":"36","author":"M Senturk","year":"2025","unstructured":"Senturk M, et al. Mean Platelet Volume Is a Poor Prognostic Factor in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Turk J Gastroenterol. 2025;36(3):169\u201373.","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"10133_CR86","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/ejh.13595","volume":"106","author":"JL Shaw","year":"2021","unstructured":"Shaw JL, et al. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. Eur J Haematol. 2021;106(5):662\u201372.","journal-title":"Eur J Haematol"},{"issue":"7","key":"10133_CR87","first-page":"1769","volume":"18","author":"W Shen","year":"2017","unstructured":"Shen W, et al. Decreased mean platelet volume is associated with cervical cancer development. Asian Pac J Cancer Prev. 2017;18(7):1769\u201372.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"10133_CR88","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/s-2007-991540","volume":"33","author":"E Sierko","year":"2007","unstructured":"Sierko E, Wojtukiewicz MZ. Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin Thromb Hemost. 2007;33(7):712\u201321.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10133_CR89","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1113\/jphysiol.2011.225417","volume":"590","author":"KY Stokes","year":"2012","unstructured":"Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol. 2012;590(5):1023\u201334.","journal-title":"J Physiol"},{"issue":"7","key":"10133_CR90","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610\u20138.","journal-title":"N Engl J Med"},{"key":"10133_CR91","doi-asserted-by":"crossref","unstructured":"Sun, S., et al., The clinical implications of mean platelet volume and mean platelet volume\/platelet count ratio in locally advanced esophageal squamous cell carcinoma. Dis Esophagus, 2018. 31(2).","DOI":"10.1093\/dote\/dox125"},{"issue":"6","key":"10133_CR92","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12664-018-0915-0","volume":"37","author":"S Tellapuri","year":"2018","unstructured":"Tellapuri S, et al. Staging systems of hepatocellular carcinoma: a review. Indian J Gastroenterol. 2018;37(6):481\u201391.","journal-title":"Indian J Gastroenterol"},{"issue":"5","key":"10133_CR93","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.devcel.2011.04.008","volume":"20","author":"MR Tijssen","year":"2011","unstructured":"Tijssen MR, et al. Genome-wide analysis of simultaneous GATA1\/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20(5):597\u2013609.","journal-title":"Dev Cell"},{"issue":"21","key":"10133_CR94","first-page":"5071","volume":"56","author":"M Trikha","year":"1996","unstructured":"Trikha M, et al. Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin. Cancer Res. 1996;56(21):5071\u20138.","journal-title":"Cancer Res"},{"key":"10133_CR95","unstructured":"In T Veld, S.G.J.G., et al., Detection and localization of early- and late-stage cancers using platelet RNA. Cancer Cell, 2022. 40(9):999\u20131009.e6."},{"issue":"17\u201318","key":"10133_CR96","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1101\/gad.327056.119","volume":"33","author":"N Venkateswaran","year":"2019","unstructured":"Venkateswaran N, et al. MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer. Genes Dev. 2019;33(17\u201318):1236\u201351.","journal-title":"Genes Dev"},{"issue":"10","key":"10133_CR97","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1073\/pnas.95.10.5556","volume":"95","author":"AS Weyrich","year":"1998","unstructured":"Weyrich AS, et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A. 1998;95(10):5556\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10133_CR98","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10555-017-9673-1","volume":"36","author":"MZ Wojtukiewicz","year":"2017","unstructured":"Wojtukiewicz MZ, et al. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017;36(2):249\u201362.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"10133_CR99","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1021\/acs.analchem.4c03855","volume":"97","author":"X Xie","year":"2025","unstructured":"Xie X, et al. Integrative quantitative analysis of platelet proteome and site-specific glycoproteome reveals diagnostic potential of platelet glycoproteins for liver cancer. Anal Chem. 2025;97(3):1546\u201356.","journal-title":"Anal Chem"},{"issue":"1","key":"10133_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00018-024-05526-3","volume":"82","author":"W Yao","year":"2024","unstructured":"Yao W, Zhao K, Li X. Platelet stimulation-regulated expression of ILK and ITGB3 contributes to intrahepatic cholangiocarcinoma progression through FAK\/PI3K\/AKT pathway activation. Cell Mol Life Sci. 2024;82(1):19.","journal-title":"Cell Mol Life Sci"},{"key":"10133_CR101","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1038\/ncomms6256","volume":"5","author":"L Yu","year":"2014","unstructured":"Yu L, et al. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat Commun. 2014;5:5256.","journal-title":"Nat Commun"},{"issue":"4","key":"10133_CR102","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4149\/neo_2017_414","volume":"64","author":"YJ Yu","year":"2017","unstructured":"Yu YJ, et al. Preoperative mean platelet volume and platelet distribution associated with thyroid cancer. Neoplasma. 2017;64(4):594\u20138.","journal-title":"Neoplasma"},{"key":"10133_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.764119","volume":"11","author":"L Yu","year":"2021","unstructured":"Yu L, et al. Bidirectional interaction between cancer cells and platelets provides potential strategies for cancer therapies. Front Oncol. 2021;11:764119.","journal-title":"Front Oncol"},{"issue":"6","key":"10133_CR104","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s10147-017-1158-2","volume":"22","author":"Z Yun","year":"2017","unstructured":"Yun Z, et al. Association of decreased mean platelet volume with renal cell carcinoma. Int J Clin Oncol. 2017;22(6):1076\u201380.","journal-title":"Int J Clin Oncol"},{"key":"10133_CR105","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.biopha.2018.05.074","volume":"105","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, et al. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients. Biomed Pharmacother. 2018;105:204\u201314.","journal-title":"Biomed Pharmacother"},{"key":"10133_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101218","author":"P Zhang","year":"2025","unstructured":"Zhang P, et al. Unveiling the \u201cdark matter\u201d of platelet involvement in tumor microenvironment. J Pharm Anal. 2025. https:\/\/doi.org\/10.1016\/j.jpha.2025.101218.","journal-title":"J Pharm Anal"},{"issue":"4","key":"10133_CR107","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.7150\/jca.103757","volume":"16","author":"C Zhong","year":"2025","unstructured":"Zhong C, et al. TGF-beta secreted by cancer cells-platelets interaction activates cancer metastasis potential by inducing metabolic reprogramming and bioenergetic adaptation. J Cancer. 2025;16(4):1310\u201323.","journal-title":"J Cancer"},{"issue":"12","key":"10133_CR108","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41590-023-01662-3","volume":"24","author":"L Zhou","year":"2023","unstructured":"Zhou L, et al. Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1. Nat Immunol. 2023;24(12):2042\u201352.","journal-title":"Nat Immunol"},{"issue":"8","key":"10133_CR109","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.7150\/jca.67428","volume":"13","author":"R Zu","year":"2022","unstructured":"Zu R, et al. A new classifier constructed with platelet features for malignant and benign pulmonary nodules based on prospective real-world data. J Cancer. 2022;13(8):2515\u201327.","journal-title":"J Cancer"},{"issue":"7","key":"10133_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70544","volume":"29","author":"R Zu","year":"2025","unstructured":"Zu R, et al. The FLNA gene in tumour-educated platelets can be utilised to identify high-risk populations for NSCLCs. J Cell Mol Med. 2025;29(7):e70544.","journal-title":"J Cell Mol Med"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10133-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:02:23Z","timestamp":1768359743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10133-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10133"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10133-4","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval or consent to participate is involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}